Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab After SIRT in HCC
NCT03380130Phase 2Completed
- Sponsor
- Universidad de Navarra
- Start
- Sep 2017
- Primary completion
- Mar 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in hepatocellular carcinoma (HCC), sponsored by Universidad de Navarra. Started Sep 2017; status: completed.
02
Drugs
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03380130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380130.